Cargando…
Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome
BACKGROUND: This study aims to investigate the prognostic significance of transthyretin in newly diagnosed myelodysplastic syndromes (MDS). METHODS: The clinical, laboratory, and follow-up data of 280 newly diagnosed patients with MDS were collected. The relationship between serum transthyretin leve...
Autores principales: | Chen, Ying, Niu, Tingting, Chen, Ting, Wu, Yue, Zou, Duobing, Shi, Cong, Wu, Ying, Zhang, Zhaoyi, Wu, Ningning, Zhang, Yi, Yan, Xiao, Sheng, Lixia, Lv, Dingfeng, Ouyang, Guifang, Chen, Xueqin, Mu, Qitian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027903/ https://www.ncbi.nlm.nih.gov/pubmed/36960201 http://dx.doi.org/10.3389/fnut.2023.1125768 |
Ejemplares similares
-
MLL-SEPT5 Fusion Transcript in Myelodysplastic Syndrome Patient With t(11;22)(q23;q11)
por: Zou, Duobing, et al.
Publicado: (2021) -
Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome
por: Shi, Cong, et al.
Publicado: (2022) -
Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes
por: Shi, Cong, et al.
Publicado: (2022) -
Prognostic significance of U2AF1 mutations in
myelodysplastic syndromes: a meta-analysis
por: Li, Bixia, et al.
Publicado: (2019) -
Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes
por: Wu, An, et al.
Publicado: (2021)